Lawmaker wants better enforcement of TV ads placed by lawyers; more toddlers are taking antipsychotics; Neurocrine puts off price disclosure of new drug
Five things for pharma marketers to know: Wednesday, April 5, 2017
GSK pulls ads from “The O’Reilly Factor”; the FDA approves drug for Huntington’s disease patients; lawmakers may remove pre-existing conditions requirement
The 2017 DTC Report: All the data in one place
March 29, 2017
11:00 am
Drugmakers again spent more on DTC advertising in 2016 than the year before.